Comparison of three lubricant eye drop solutions in dry eye patients

Optometry and Vision Science

Volumn 88, Issue 12, 2011, Pages 1439-1444

  Evangelista, Mariasilva ^a,c   Koverech, Aleardo ^b   Messano, Masa ^b   Pescosolido, Nicola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Sigma Tau SpA   (Italy)

^c NONE   (Italy)

Author keywords

Dry eye syndrome; FBUT; L Carnitine; lubricant eye drops; OPI; osmolarity

Indexed keywords

DRY EYE; FBUT; L-CARNITINE; OPI; OSMOLARITY;

CATIONIC SURFACTANTS; CHLORINE COMPOUNDS; QUALITY CONTROL;

DROPS;

EYE DROPS;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; LACRIMAL FLUID; MALE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TEARS; TREATMENT OUTCOME;

EID: 82155162458     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3182348c28     Document Type: Article

References (23)

1. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78: 347-60. (Pubitemid 38183311)
2. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res 2004;78:379-88. (Pubitemid 38183315)
3. Pescosolido N, Imperatrice B, Koverech A, Messano M. L-carnitine and short chain ester in tears from patients with dry eye. Optom Vis Sci 2009;86:132-8.
4. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006;47:4309-15. (Pubitemid 46579353)
5. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5: 179-93.
6. Stewart P, Chen Z, Farley W, Olmos L, Pflugfelder SC. Effect of experimental dry eye on tear sodium concentration in the mouse. Eye Contact Lens 2005;31:175-8. (Pubitemid 43197021)
7. Johansson N, Ala-aho R, Uitto V, Grenman R, Fusenig NE, Lopez-Otin C, Kahari VM. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000;113(Pt 2):227-35. (Pubitemid 30088968)
8. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001;73:449-59. (Pubitemid 33078221)
9. Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol 1981;26:84-96. (Pubitemid 11022563)
10. Jackson WB. Management of dysfunctional tear syndrome: a Canadian consensus. Can J Ophthalmol 2009;44:385-94.
11. Abelson MB, Ousler GW, III, Maffei C. Dry eye in 2008. Curr Opin Ophthalmol 2009;20:282-6.
12. Gilbard JP, Rossi SR, Heyda KG. Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation. Am J Ophthalmol 1989;107:348-55. (Pubitemid 19100925)
13. Gilbard JP. Human tear film electrolyte concentrations in health and dry-eye disease. Int Ophthalmol Clin 1994;34:27-36. (Pubitemid 24068456)
14. Laurie GW, Olsakovsky LA, Conway BP, McKown RL, Kitagawa K, Nichols JJ. Dry eye and designer ophthalmics. Optom Vis Sci 2008; 85:643-52.
15. Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-4. (Pubitemid 34127543)
16. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008;17:350-5.
17. Isreb MA, Greiner JV, Korb DR, Glonek T, Mody SS, Finnemore VM, Reddy CV. Correlation of lipid layer thickness measurements with fluorescein tear film break-up time and Schirmer's test. Eye 2003;17:79-83. (Pubitemid 36181843)
18. Ousler GW, III, Hagberg KW, Schindelar M, Welch D, Abelson MB. The Ocular Protection Index. Cornea 2008;27:509-13.
19. Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol 2000;11:241-7. (Pubitemid 30490801)
20. Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010;128: 94-101.
21. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol 2008;86: 716-26.
22. Peluso G, Barbarisi A, Savica V, Reda E, Nicolai R, Benatti P, Calvani M. Carnitine: an osmolyte that plays a metabolic role. J Cell Biochem 2000;80:1-10.
23. Pessotto P, Liberati R, Petrella O, Romanelli L, Calvani M, Peluso G. In experimental diabetes the decrease in the eye of lens carnitine levels is an early important and selective event. Exp Eye Res 1997;64: 195-201. (Pubitemid 27139565)